MYMX.US Mymetics Corp

Healthcare Biotechnology USA Stocks
0.0003 USD
Close of Nov 16, 2026
0.0003 0.0003
Market cap
USD 45.00
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is MYMX.US undervalued?

Graham number

The Graham number of Mymetics Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mymetics Corp fundamental analysis

No fundamental analysis for Mymetics Corp yet.

Mymetics Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mymetics Corp

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health. The company was formerly known as ICHOR Corporation and …

Full company profile